France Confirms First Ever Human Case of Shamonda Virus After Patient Dies in Lyon.
In a development that has caught the attention of global health authorities, France confirmed on October 22, 2026, that a patient treated in Lyon had been infected with the Shamonda virus before dying in early October. This marks the first documented human case of a virus that, until now, had only ever been detected in animals.
The patient, whose identity remains confidential, was being treated for a serious underlying illness that had left them with severe immune deficiency. Investigators believe the person was infected earlier this year through the bite of a Culicoides midge a tiny biting fly in eastern France, where the virus was circulating among livestock throughout spring and summer. The patient died in early October, and French health officials say the neurological complications observed before death were very likely linked to the infection.
Shamonda virus belongs to the same viral family as Schmallenberg virus and Akabane virus, both of which cause reproductive disease in livestock. It was first isolated from cattle and biting midges in Nigeria in 1965 and has since been reported sporadically in cattle, sheep, goats, horses, and alpacas across parts of Africa and Japan. Until this case, viruses in the Simbu serogroup were not considered capable of infecting humans.
The virus is transmitted by Culicoides midges rather than through direct contact between animals. In cattle and other ruminants, infection typically causes fever, reduced milk yield, lethargy, and diarrhoea in adult animals. However, its more serious effects strike during pregnancy, with infection linked to miscarriage, stillbirth, and severe congenital malformations in newborn calves and lambs.
French officials have stressed that this is an exceptional case tied specifically to the patient's severe immunodeficiency, which likely allowed a virus that would not normally cause illness in a healthy person to take hold. WHO Director General Tedros Adhanom Ghebreyesus noted that the patient lived in an area where the virus was already circulating in animals and where the midge vector was present consistent with incidental exposure rather than any new or more dangerous strain. Authorities have not identified any transmission risk between humans, and no additional human cases have been reported.
The virus's emergence in Europe was first confirmed in early August 2026, when Germany's Friedrich Loeffler Institute identified a closely related orthobunyavirus in cattle. Since then, the virus or closely related variants have been confirmed in livestock across France, Switzerland, Austria, Belgium, Ireland, Italy, Liechtenstein, Luxembourg, the Netherlands, Portugal, Slovenia, Spain, and Jersey.
While authorities continue to downplay any immediate danger to the public, the case represents a significant moment for disease surveillance a virus with a 60 year history in animals has, under exceptional circumstances, made the leap into a human host. French authorities, the WHO, and the European CDC are continuing investigations into exactly how the patient was infected and what the infection reveals about the virus's behaviour in human tissue.
For now, the case stands as a reminder of why continuous veterinary and public health surveillance of circulating animal viruses remains a frontline tool for catching emerging disease risks early.